BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38771530)

  • 1. Disentangling the heterogeneity of multiple sclerosis through identification of independent neuropathological dimensions.
    de Boer A; van den Bosch AMR; Mekkes NJ; Fransen NL; Dagkesamanskaia E; Hoekstra E; Hamann J; Smolders J; Huitinga I; Holtman IR
    Acta Neuropathol; 2024 May; 147(1):90. PubMed ID: 38771530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: a retrospective autopsy cohort analysis.
    Luchetti S; Fransen NL; van Eden CG; Ramaglia V; Mason M; Huitinga I
    Acta Neuropathol; 2018 Apr; 135(4):511-528. PubMed ID: 29441412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-mortem multiple sclerosis lesion pathology is influenced by single nucleotide polymorphisms.
    Fransen NL; Crusius JBA; Smolders J; Mizee MR; van Eden CG; Luchetti S; Remmerswaal EBM; Hamann J; Mason MRJ; Huitinga I
    Brain Pathol; 2020 Jan; 30(1):106-119. PubMed ID: 31228212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofilament Light Chain Levels in Multiple Sclerosis Correlate With Lesions Containing Foamy Macrophages and With Acute Axonal Damage.
    van den Bosch A; Fransen N; Mason M; Rozemuller AJ; Teunissen C; Smolders J; Huitinga I
    Neurol Neuroimmunol Neuroinflamm; 2022 May; 9(3):. PubMed ID: 35241571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions.
    Fransen NL; Hsiao CC; van der Poel M; Engelenburg HJ; Verdaasdonk K; Vincenten MCJ; Remmerswaal EBM; Kuhlmann T; Mason MRJ; Hamann J; Smolders J; Huitinga I
    Brain; 2020 Jun; 143(6):1714-1730. PubMed ID: 32400866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Ependymal-in" Gradient of Thalamic Damage in Progressive Multiple Sclerosis.
    Magliozzi R; Fadda G; Brown RA; Bar-Or A; Howell OW; Hametner S; Marastoni D; Poli A; Nicholas R; Calabrese M; Monaco S; Reynolds R
    Ann Neurol; 2022 Oct; 92(4):670-685. PubMed ID: 35748636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis.
    Nutma E; Stephenson JA; Gorter RP; de Bruin J; Boucherie DM; Donat CK; Breur M; van der Valk P; Matthews PM; Owen DR; Amor S
    Brain; 2019 Nov; 142(11):3440-3455. PubMed ID: 31578541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meningeal inflammation and cortical demyelination in acute multiple sclerosis.
    Bevan RJ; Evans R; Griffiths L; Watkins LM; Rees MI; Magliozzi R; Allen I; McDonnell G; Kee R; Naughton M; Fitzgerald DC; Reynolds R; Neal JW; Howell OW
    Ann Neurol; 2018 Dec; 84(6):829-842. PubMed ID: 30362156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staining of HLA-DR, Iba1 and CD68 in human microglia reveals partially overlapping expression depending on cellular morphology and pathology.
    Hendrickx DAE; van Eden CG; Schuurman KG; Hamann J; Huitinga I
    J Neuroimmunol; 2017 Aug; 309():12-22. PubMed ID: 28601280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging.
    Dal-Bianco A; Grabner G; Kronnerwetter C; Weber M; Höftberger R; Berger T; Auff E; Leutmezer F; Trattnig S; Lassmann H; Bagnato F; Hametner S
    Acta Neuropathol; 2017 Jan; 133(1):25-42. PubMed ID: 27796537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons.
    Singh S; Metz I; Amor S; van der Valk P; Stadelmann C; Brück W
    Acta Neuropathol; 2013 Apr; 125(4):595-608. PubMed ID: 23354834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of microglial TMEM119 and P2RY12 immunoreactivity in multiple sclerosis white and grey matter lesions is dependent on their inflammatory environment.
    van Wageningen TA; Vlaar E; Kooij G; Jongenelen CAM; Geurts JJG; van Dam AM
    Acta Neuropathol Commun; 2019 Dec; 7(1):206. PubMed ID: 31829283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglia and astroglia proliferation within the normal appearing white matter in histologically active and inactive multiple sclerosis.
    Nowacki P; Koziarska D; Masztalewicz M
    Folia Neuropathol; 2019; 57(3):249-257. PubMed ID: 31588711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digital Pathology Identifies Associations between Tissue Inflammatory Biomarkers and Multiple Sclerosis Outcomes.
    Cooze B; Neal J; Vineed A; Oliveira JC; Griffiths L; Allen KH; Hawkins K; Yadanar H; Gerhards K; Farkas I; Reynolds R; Howell O
    Cells; 2024 Jun; 13(12):. PubMed ID: 38920650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of cortical lesions in multiple sclerosis: clinical and pathologic implications.
    Kooi EJ; Strijbis EM; van der Valk P; Geurts JJ
    Neurology; 2012 Sep; 79(13):1369-76. PubMed ID: 22972651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement is activated in progressive multiple sclerosis cortical grey matter lesions.
    Watkins LM; Neal JW; Loveless S; Michailidou I; Ramaglia V; Rees MI; Reynolds R; Robertson NP; Morgan BP; Howell OW
    J Neuroinflammation; 2016 Jun; 13(1):161. PubMed ID: 27333900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An updated histological classification system for multiple sclerosis lesions.
    Kuhlmann T; Ludwin S; Prat A; Antel J; Brück W; Lassmann H
    Acta Neuropathol; 2017 Jan; 133(1):13-24. PubMed ID: 27988845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.
    Schmierer K; Parkes HG; So PW; An SF; Brandner S; Ordidge RJ; Yousry TA; Miller DH
    Brain; 2010 Mar; 133(Pt 3):858-67. PubMed ID: 20123726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis and Alzheimer's disease.
    Dal Bianco A; Bradl M; Frischer J; Kutzelnigg A; Jellinger K; Lassmann H
    Ann Neurol; 2008 Feb; 63(2):174-83. PubMed ID: 17924575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homogeneity of active demyelinating lesions in established multiple sclerosis.
    Breij EC; Brink BP; Veerhuis R; van den Berg C; Vloet R; Yan R; Dijkstra CD; van der Valk P; Bö L
    Ann Neurol; 2008 Jan; 63(1):16-25. PubMed ID: 18232012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.